Banner News

Taiwan, February 24, 2022 – Credo Diagnostics presents at Medical Japan Osaka on February 24 - 26, 2022.


Medical Japan is Japan’s leading trade show consisting of specialized shows for the Medical, Elderly Care, and Pharmacy industries. This exhibition consists of 5 shows, including hospital exposition, clinics exposition, pharmacy solutions exposition, elderly care & nursing exposition, infection prevention exposition.


As one of the leading brands in molecular diagnostics, Credo Diagnostics shows the most innovative, cost-effective, and rapid molecular diagnostic solutions at Medical Japan Osaka. We are conscious of the necessity to simplify processes and accelerate molecular testing at affordable costs. Credo Diagnostics believes that effective and rapid Point-Of-Care (POC) testing will redefine molecular diagnostics in human healthcare.

Look for our exhibition stand at booth 9-21 and find the most innovative POCT solution, VitaPCR™.



【Medical Japan 2022 Osaka】

◾ Date: February 24 (Thu) - 26 (Sat), 2022

◾ Venue: INTEX Osaka, Japan

◾ Booth No.: 9-21 (Hall 5)

◾ Exhibition Website

◾ E-Invitation Ticket


Medical JP w1000

 Credo Diagnostics Booth – Medical Japan Osaka, 2022  





About Credo Diagnostics Biomedical Pte. Ltd.

Credo Diagnostics develops and manufactures innovative, easy-to-use and rapid molecular diagnostic solutions for Point-of-Care (POC) applications at affordable costs without compromising accuracy and speed in the areas Human Health. Leveraging solid and established science, combined with efficient integration and strategic innovation, Credo Diagnostics Biomedical provides advanced medical technologies for all.


We at Credo Diagnostics pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.